ACHV
Price
$7.06
Change
-$0.22 (-3.02%)
Updated
Sep 11 closing price
Capitalization
726.49M
54 days until earnings call
Intraday BUY SELL Signals
BEAM
Price
$23.99
Change
-$0.38 (-1.56%)
Updated
Sep 11 closing price
Capitalization
2.48B
58 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ACHV vs BEAM

ACHV vs BEAM Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ACHV vs. BEAM commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACHV is a Hold and BEAM is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.48B) has a higher market cap than ACHV($726M). ACHV YTD gains are higher at: 42.052 vs. BEAM (-13.456). ACHV has higher annual earnings (EBITDA): -112.82M vs. BEAM (-355.78M). BEAM has more cash in the bank: 1.15B vs. ACHV (187M). ACHV has less debt than BEAM: ACHV (14.9M) vs BEAM (247M). BEAM has higher revenues than ACHV: BEAM (156M) vs ACHV (0).
ACHVBEAMACHV / BEAM
Capitalization726M2.48B29%
EBITDA-112.82M-355.78M32%
Gain YTD42.052-13.456-313%
P/E RatioN/AN/A-
Revenue0156M-
Total Cash187M1.15B16%
Total Debt14.9M247M6%
FUNDAMENTALS RATINGS
ACHV vs BEAM: Fundamental Ratings
ACHV
BEAM
OUTLOOK RATING
1..100
738
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
24
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10092
PRICE GROWTH RATING
1..100
3560
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BEAM's Valuation (24) in the null industry is somewhat better than the same rating for ACHV (81) in the Biotechnology industry. This means that BEAM’s stock grew somewhat faster than ACHV’s over the last 12 months.

BEAM's Profit vs Risk Rating (100) in the null industry is in the same range as ACHV (100) in the Biotechnology industry. This means that BEAM’s stock grew similarly to ACHV’s over the last 12 months.

BEAM's SMR Rating (92) in the null industry is in the same range as ACHV (100) in the Biotechnology industry. This means that BEAM’s stock grew similarly to ACHV’s over the last 12 months.

ACHV's Price Growth Rating (35) in the Biotechnology industry is in the same range as BEAM (60) in the null industry. This means that ACHV’s stock grew similarly to BEAM’s over the last 12 months.

ACHV's P/E Growth Rating (100) in the Biotechnology industry is in the same range as BEAM (100) in the null industry. This means that ACHV’s stock grew similarly to BEAM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACHVBEAM
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 11 days ago
81%
Bullish Trend 9 days ago
76%
Declines
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
79%
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
71%
COMPARISON
Comparison
Sep 12, 2026
Stock price -- (ACHV: $7.06 vs. BEAM: $23.99)
Brand notoriety: ACHV and BEAM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACHV: 94% vs. BEAM: 59%
Market capitalization -- ACHV: $726.49M vs. BEAM: $2.48B
ACHV [@Biotechnology] is valued at $726.49M. BEAM’s [@Biotechnology] market capitalization is $2.48B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.64B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACHV’s FA Score shows that 0 FA rating(s) are green while BEAM’s FA Score has 1 green FA rating(s).

  • ACHV’s FA Score: 0 green, 5 red.
  • BEAM’s FA Score: 1 green, 4 red.
According to our system of comparison, BEAM is a better buy in the long-term than ACHV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACHV’s TA Score shows that 4 TA indicator(s) are bullish while BEAM’s TA Score has 5 bullish TA indicator(s).

  • ACHV’s TA Score: 4 bullish, 4 bearish.
  • BEAM’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both ACHV and BEAM are a good buy in the short-term.

Price Growth

ACHV (@Biotechnology) experienced а -16.84% price change this week, while BEAM (@Biotechnology) price change was -19.12% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.

Reported Earning Dates

ACHV is expected to report earnings on Nov 05, 2026.

BEAM is expected to report earnings on Nov 09, 2026.

Industries' Descriptions

@Biotechnology (-6.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
ACHV
Daily Signal:
Gain/Loss:
BEAM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PRGFX109.17N/A
N/A
T. Rowe Price Growth Stock
LBWAX24.66N/A
N/A
BrandywineGLOBAL Div US Large Value A
MRRGX30.49N/A
N/A
Meridian Growth Institutional
TRHBX30.25N/A
N/A
Nuveen Small Cap Blend Idx I
MXECX12.39N/A
N/A
Empower Core Strategies Intl Eq Instl